Skip to main content

Table 1 Patient baseline characteristics

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

  All patients Pt. with eGFR≥45 Pt. with eGFR< 45 p
n 189 116 73  
Male sex, n (%) 116 (61.4) 74 (63.8) 42 (57.5) 0.18
Mean age (years) 73.4 ± 7.9 72.1 ± 8.0 75.9 ± 6.7 0.10
BMI (kg/m2) 29.3 ± 5.4 28.94 ± 5.5 29.28 ± 5.2 0.83
BSA (m2) 1.96 ± 0.23 1.96 ± 0.20 1.95 ± 0.24 0.58
CHA2DS2-VASc score 3.88 ± 1.6 3.40 ± 1.57 4.50 ± 1.42 < 0.01
HAS-BLED – Score 3.35 ± 1.0 3.13 ± 0.9 3.65 ± 1.0 < 0.01
Arterial hypertension, n (%) 164 (86.8) 98 (84.5) 66 (90.4) 0.32
Diabetes mellitus, n (%) 85 (45.0) 40 (34.5) 45 (61.6) < 0.01
Hyperlipidaemia, n (%) 94 (49.7) 56 (48.3) 38 (52.1) 0.42
Smoking status
 non-smoker, n (%) 138 (73.0) 81 (69.8) 57 (78.1) 0.12
 smoker, n (%) 25 (13.2) 15 (12.9) 10 (13.7) 0.70
 stopped smoking, n (%) 26 (13.8) 20 (17.2) 6 (8.2) 0.10
Atrial fibrillation
 paroxysmal, n (%) 75 (39.7) 48 (41.4) 27 (37.0) 0.33
 pers./perm., n (%) 114 (60.3) 68 (58.6) 46 (63.0)  
Previous stroke / TIA, n (%) 33 (17.2) 21 (17.5) 12 (16.4) 0.80